CRI OPENS
NEW OVARIAN CANCER CLINICAL TRIAL
The first patients have been dosed
in a new multi-center clinical trial testing new immunotherapy combinations
in patients with an aggressive form of ovarian cancer that resists treatment
with chemotherapy. |
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Tuesday, July 5, 2022
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment